These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 8638796)

  • 1. In vitro diagnosis of malignant hyperthermia susceptibility with ryanodine-induced contractures in human skeletal muscles.
    Wappler F; Roewer N; Köchling A; Scholz J; Steinfath M; Schulte am Esch J
    Anesth Analg; 1996 Jun; 82(6):1230-6. PubMed ID: 8638796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [4-chloro-m-cresol-induced contractures of skeletal muscle specimen from patients at risk for malignant hyperthermia].
    Wappler F; Scholz J; von Richthofen V; Fiege M; Steinfath M; Schulte am Esch J
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1997 Sep; 32(9):541-8. PubMed ID: 9417254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Diagnosis of susceptibility to malignant hyperthermia with an in vitro contracture test with the phosphodiesterase iii inhibitor enoximone].
    Fiege M; Wappler F; Scholz J; von Richthofen V; Brinken B; Schulte am Esch J
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1998 Sep; 33(9):557-63. PubMed ID: 9787864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Malignant hyperthermia (MH) diagnostics: a comparison between the halothane-caffeine- and the ryanodine-contracture-test results in MH susceptible, normal and control muscle.
    Hartung E; Koob M; Anetseder M; Schoemig P; Krauspe R; Hogrefe G; Engelhardt W
    Acta Anaesthesiol Scand; 1996 Apr; 40(4):437-44. PubMed ID: 8738688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ryanodine contracture threshold times for diagnosis of malignant hyperthermia susceptibility: an experimental approach from a single laboratory.
    Weisshorn R; Wappler F; Fiege M; Gerbershagen MU; Kolodzie K; Alberts P; Horn EP; Schulte Am Esch J
    J Clin Anesth; 2004 Aug; 16(5):353-7. PubMed ID: 15374556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-purity ryanodine and 9,21-dehydroryanodine for in vitro diagnosis of malignant hyperthermia in man.
    Wappler F; Roewer N; Lenzen C; Köchling A; Scholz J; Steinfath M; Schulte am Esch J
    Br J Anaesth; 1994 Feb; 72(2):240-2. PubMed ID: 8110584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of the phosphodiesterase-III inhibitor enoximone on skeletal muscle specimens from malignant hyperthermia susceptible patients.
    Fiege M; Wappler F; Scholz J; Weisshorn R; von Richthofen V; Schulte am Esch J
    J Clin Anesth; 2000 Mar; 12(2):123-8. PubMed ID: 10818326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of the serotonin2 receptor agonist DOI on skeletal muscle specimens from malignant hyperthermia-susceptible patients.
    Wappler F; Roewer N; Köchling A; Scholz J; Löscher W; Steinfath M
    Anesthesiology; 1996 Jun; 84(6):1280-7. PubMed ID: 8669667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C1840-T mutation in the human skeletal muscle ryanodine receptor gene: frequency in northern German families susceptible to malignant hyperthermia and the relationship to in vitro contracture response.
    Steinfath M; Singh S; Scholz J; Becker K; Lenzen C; Wappler F; Köchling A; Roewer N; Schulte am Esch J
    J Mol Med (Berl); 1995 Jan; 73(1):35-40. PubMed ID: 7633940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Attenuation of serotonin-induced contractures in skeletal muscle from malignant hyperthermia-susceptible patients with dantrolene.
    Wappler F; Scholz J; von Richthofen V; Fiege M; Köchling A; Lambrecht W; Schulte am Esch J
    Acta Anaesthesiol Scand; 1997 Nov; 41(10):1312-8. PubMed ID: 9422298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ritanserin attenuates the in vitro effects of the 5-HT2 receptor agonist DOI on skeletal muscles from malignant hyperthermia-susceptible patients.
    Wappler F; Scholz J; Oppermann S; von Richthofen V; Steinfath M; Schulte am Esch J
    J Clin Anesth; 1997 Jun; 9(4):306-11. PubMed ID: 9195354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in ryanodine-induced contractures by stimulus frequency in malignant hyperthermia susceptible and malignant hyperthermia nonsusceptible dog skeletal muscle.
    Sudo RT; Nelson TE
    J Pharmacol Exp Ther; 1997 Sep; 282(3):1331-6. PubMed ID: 9316843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of serotonin 2 receptor agonists on skeletal muscle preparations in patients with a disposition toward malignant hyperthermia].
    Wappler F; Roewer N; Köchling A; Scholz J; Steinfath M; Rumberger E; Löscher W; Schulte am Esch J
    Anaesthesist; 1995 Aug; 44(8):538-44. PubMed ID: 7573901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [High purity ryanodine for in vitro diagnosis of malignant hyperthermia].
    Wappler F; Roewer N; Lenzen C; Scholz J; Steinfath M; Rumberger R; Schulte am Esch J
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1993 Nov; 28(7):427-31. PubMed ID: 8297948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inositol 1,4,5-trisphosphate in blood and skeletal muscle in human malignant hyperthermia.
    Wappler F; Scholz J; Köchling A; Steinfath M; Krause T; Schulte am Esch J
    Br J Anaesth; 1997 May; 78(5):541-7. PubMed ID: 9175969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Ryanodine-induced contractures for the diagnosis of malignant hyperthermia susceptibility].
    Lenzen C; Roewer N; Scholz J; Rumberger E; Schulte am Esch J
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1991 Dec; 26(8):459-63. PubMed ID: 1786306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sources of variability in halothane and caffeine contracture tests for susceptibility to malignant hyperthermia.
    Ording H; Bendixen D
    Eur J Anaesthesiol; 1992 Sep; 9(5):367-76. PubMed ID: 1396623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Is a presymptomatic malignant hyperthermia in-vitro diagnosis with 4-chloro-3-ethyl phenol possible? A study using porcine skeletal preparations].
    Gerbershagen MU; Wappler F; Fiege M; Weisshorn R; Kolodzie K; Schulte am Esch J
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2004 Feb; 39(2):81-6. PubMed ID: 14767797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 3,5-Di-t-butyl catechol is a potent human ryanodine receptor 1 activator, not suitable for the diagnosis of malignant hyperthermia susceptibility.
    Lacava C; Michalek-Sauberer A; Kraft B; Sgaragli G; Sipos E; Höller C; Kress HG; Fusi F; Weigl LG
    Pharmacol Res; 2012 Jul; 66(1):80-7. PubMed ID: 22480578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accelerated contractures after administration of ryanodine to skeletal muscle of malignant hyperthermia susceptible patients.
    Lenzen C; Roewer N; Wappler F; Scholz J; Kahl J; Blank M; Rumberger E; Schulte am Esch J
    Br J Anaesth; 1993 Aug; 71(2):242-6. PubMed ID: 8123400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.